What is Mineralys Therapeutics, Inc.'s capex?

Mineralys Therapeutics, Inc. (MLYS) reported capex of $15K in Q4 2025.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Mineralys Therapeutics, Inc. MLYS CapEx

Discontinued — last reported Q4 '25

CapEx at other companies

Crinetics PharmaceuticalsCRNX

$820K-33.8%

Stoke Therapeutics, Inc.STOK

$353K+132%

Kiniksa Pharmaceuticals International, plcKNSA

$161K+62.6%

CytokineticsCYTK

$5.93M+4.7%

Septerna, Inc.SEPN

$832K+118%

Tenet HealthcareTHC

$180M+4.0%

Other financials

Income statement

See full

Operating income-$45.3M-2.0%

Net income-$39.3M+6.8%

EPS (diluted)-$0.47+40.5%

Balance sheet

See full

Cash & equivalents$1.2M-14.6%

Total equity$638.1M+86.8%

Total assets$652.9M+83.9%

Cash flow

See full

Operating cash flow-$39.5M+13.2%

Free cash flow-$37.9M+43.3%

Valuation

See full

Market cap$2.26B+124%

Returns & leverage

See full

Return on equity-31%-9.6pp

Current ratio44.3×+17.8×

Where this comes from

Reported directly by Mineralys Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireProductiveAssets.

The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mineralys Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mineralys Therapeutics, Inc.'s capex?: Mineralys Therapeutics, Inc. (MLYS) reported capex of $15K in Q4 2025.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.